Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Dreiling

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Comprehensive Therapy|September 1, 1984
Congestive heart failureR J Dreiling, M Dunn
Archives of Internal Medicine|August 1, 1985
StreptokinaseM I Dunn, R J Dreiling
The American Journal of Cardiology|December 1, 1983
Two-dimensional echocardiographic features of multiple right atrial myxomasJ R Gladden, R J Dreiling, S B Gollub, et al.
The Journal of Invasive Cardiology|September 5, 1993
Directional coronary atherectomy in acute myocardial infarctionT F Baldwin, R E Lash, S S Whitfield, et al.
Circulation|September 30, 1998
Pharmacodynamic efficacy, clinical safety, and outcomes after prolonged platelet Glycoprotein IIb/IIIa receptor blockade with oral xemilofiban: results of a multicenter, placebo-controlled, randomized trialD J Kereiakes, N S Kleiman, J J Ferguson, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Comprehensive Therapy|September 1, 1984
Congestive heart failureR J Dreiling, M Dunn
Archives of Internal Medicine|August 1, 1985
StreptokinaseM I Dunn, R J Dreiling
The American Journal of Cardiology|December 1, 1983
Two-dimensional echocardiographic features of multiple right atrial myxomasJ R Gladden, R J Dreiling, S B Gollub, et al.
The Journal of Invasive Cardiology|September 5, 1993
Directional coronary atherectomy in acute myocardial infarctionT F Baldwin, R E Lash, S S Whitfield, et al.
Circulation|September 30, 1998
Pharmacodynamic efficacy, clinical safety, and outcomes after prolonged platelet Glycoprotein IIb/IIIa receptor blockade with oral xemilofiban: results of a multicenter, placebo-controlled, randomized trialD J Kereiakes, N S Kleiman, J J Ferguson, et al.
Pageof 1